![Christian Brechot](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Christian Brechot
Directeur/Membre du Conseil chez
Fondation Mérieux
Profil
Christian Brechot is the founder of ScreenCell SA, which was founded in 2001.
He is currently the Vice Chairman at Global Virus Network, Director at Fondation Mérieux, Director at Institut Pasteur Korea Research Foundation, Director at Fondation Ophtalmologique Adolphe de Rothschild, Director at European Personalised Medicine Association, and Director at Rarecells Diagnostics SAS. Dr. Brechot's former positions include being a Director at Transgene SA, Director at Biotheranostics, Inc., Director at bioMérieux SA from 2008 to 2012, General Director at Institut National de la Santé & de la Recherche Médicale from 2001 to 2007, Director at Drugs for Neglected Diseases initiative, President at Institut Pasteur from 2013 to 2017, Vice President-Medical & Scientific Affairs at Compagnie Merieux Alliance SAS, and Head-Clinical Department at Hopital Necker-Enfants Malades.
He obtained a doctorate degree from Université Paris 1 Panthéon-Sorbonne in 1985.
Postes actifs de Christian Brechot
| Sociétés | Poste | Début |
|---|---|---|
Fondation Mérieux
 Fondation Mérieux Investment Trusts/Mutual FundsMiscellaneous Functions as a foundation or endowment | Directeur/Membre du Conseil | - |
Fondation Ophtalmologique Adolphe de Rothschild
 Fondation Ophtalmologique Adolphe de Rothschild Hospital/Nursing ManagementHealth Services Operates a hospital for the treatment and diagnosis of opthalmic and neurologic diseases | Directeur/Membre du Conseil | - |
European Personalised Medicine Association | Directeur/Membre du Conseil | - |
Institut Pasteur Korea
 Institut Pasteur Korea BiotechnologyHealth Technology Provides research and development for the treatment of infectious and chronic diseases | Directeur/Membre du Conseil | - |
Global Virus Network
 Global Virus Network Miscellaneous Commercial ServicesCommercial Services Researches on essential and critical defense against viral disease | Directeur/Membre du Conseil | - |
Rarecells Diagnostics SAS
 Rarecells Diagnostics SAS Packaged SoftwareTechnology Services Develops and commercializes ISET technology to isolate circulating cancer cells for early cancer diagnosis & medical research | Directeur/Membre du Conseil | - |
Anciens postes connus de Christian Brechot
| Sociétés | Poste | Fin |
|---|---|---|
Institut Pasteur
 Institut Pasteur Investment Trusts/Mutual FundsMiscellaneous Functions as a foundation or endowment | President | 13/10/2017 |
| BIOMÉRIEUX | Directeur/Membre du Conseil | 01/01/2012 |
Institut National de la Santé & de la Recherche Médicale
 Institut National de la Santé & de la Recherche Médicale Miscellaneous Commercial ServicesCommercial Services Research institute | Corporate Officer/Principal | 01/01/2007 |
| ░░░░░░░░░░ ░░ | ░░░░░░░░░ | - |
| ░░░░░ ░░░ ░░░░░░░░░ ░░░░░░░░ ░░░░░░░░░░ | ░░░░░░░░░░░░░░░░ ░░ ░░░░░░░ | - |
Formation de Christian Brechot
Expériences
Fonctions occupées
Actives
Inactives
Sociétés cotées
Entreprise privées
Relations
73
Relations au 1er degré
16
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
Sociétés liées
| Entreprise privées | 16 |
|---|---|
Transgene SA
 Transgene SA BiotechnologyHealth Technology Designs and develops therapeutic vaccines and oncolytic viruses for the treatment of cancer | Health Technology |
Biotheranostics, Inc.
 Biotheranostics, Inc. Medical/Nursing ServicesHealth Services Discovers, develops and commercializes molecular diagnostic tests for cancer patients | Health Services |
Institut Pasteur
Institut Pasteur Investment Trusts/Mutual FundsMiscellaneous Functions as a foundation or endowment | Miscellaneous |
bioMérieux SA
 bioMérieux SA Medical SpecialtiesHealth Technology Develops biotechnological products specializing in in-vitro diagnostics and infectious diseases | Health Technology |
Université Paris 1 Panthéon-Sorbonne
 Université Paris 1 Panthéon-Sorbonne Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Institut National de la Santé & de la Recherche Médicale
Institut National de la Santé & de la Recherche Médicale Miscellaneous Commercial ServicesCommercial Services Research institute | Commercial Services |
ScreenCell SA
 ScreenCell SA Miscellaneous Commercial ServicesCommercial Services Offers clinically confirmed solutions for the isolation of rare cells in the blood and other fluids | Commercial Services |
Fondation Mérieux
Fondation Mérieux Investment Trusts/Mutual FundsMiscellaneous Functions as a foundation or endowment | Miscellaneous |
Compagnie Merieux Alliance SAS
 Compagnie Merieux Alliance SAS Investment Trusts/Mutual FundsMiscellaneous Functions as an investment fund | Miscellaneous |
Drugs for Neglected Diseases initiative
 Drugs for Neglected Diseases initiative BiotechnologyHealth Technology Provides drug and research development services | Health Technology |
Institut Pasteur Korea
Institut Pasteur Korea BiotechnologyHealth Technology Provides research and development for the treatment of infectious and chronic diseases | Health Technology |
Hopital Necker-Enfants Malades | |
Fondation Ophtalmologique Adolphe de Rothschild
Fondation Ophtalmologique Adolphe de Rothschild Hospital/Nursing ManagementHealth Services Operates a hospital for the treatment and diagnosis of opthalmic and neurologic diseases | Health Services |
European Personalised Medicine Association | |
Global Virus Network
Global Virus Network Miscellaneous Commercial ServicesCommercial Services Researches on essential and critical defense against viral disease | Commercial Services |
Rarecells Diagnostics SAS
Rarecells Diagnostics SAS Packaged SoftwareTechnology Services Develops and commercializes ISET technology to isolate circulating cancer cells for early cancer diagnosis & medical research | Technology Services |
